Clinical Trial Update: Phase 2 Study of Gemcitabine and Docetaxel Combination Chemotherapy in Patients With Carcinoma of Unknown Primary [Phase 2]

View source ↗

Summary

Phase 2 study evaluating gemcitabine and docetaxel chemotherapy in patients with carcinoma of unknown primary.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoma of Unknown Primary

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Samsung Medical Center | Conditions: Carcinoma of Unknown Primary | Phase 2 | Status: UNKNOWN